Article Data

  • Views 1155
  • Dowloads 123

Case Reports

Open Access

Malignant mixed mtillerian tumor of the ovary and false negative punctures

  • P. Cryns1
  • N. J. L. Roofthooft1
  • W. A. A. Tjalma1,*,

1Department of Gynaecologic Oncology, University Hospital Antwerp, Belgium

DOI: 10.12892/ejgo20030170 Vol.24,Issue 1,January 2003 pp.70-72

Published: 10 January 2003

*Corresponding Author(s): W. A. A. Tjalma E-mail:

Abstract

Malignant mixed müllerian tumour (MMMT) of the ovary is a rare and aggressive tumour with a poor prognosis. We present a case of a 57-year-old woman with a large pelvic mass, omental cake, ascites and pleural effusions, clinically highly suspect of an ovarian neoplasm. Paracentesis and ultrasound-guided biopsy of the ovary were negative for malignant disease. Therefore a CT-guided true cut biopsy was performed. The latter gave a histopathologic diagnosis of an endometrioid adenocarcinoma of the ovary. However after cytoreductive surgery anatomopathologic examination revealed a malignant mixed müllerian tumour of the ovary with heterologous differentiation. Apparently only one of the two components was found in the puncture. Adjuvant chemotherapy, active against the sarcomatous and the carcinomatous component, was given. At present the patient is well and disease free 35 months after the initial diagnosis. Cytological examination of ascites may be negative in the presence of malignant disease. If a tumour consists of two components, puncture can miss one, which may lead to undertreatment. Punctures should be discouraged as a diagnostic tool in patients in whom an ovarian malignancy is suspected.

Keywords

Ovarian neoplasm; Biopsy; Malignant mixed miillerian tumour; Puncture

Cite and Share

P. Cryns,N. J. L. Roofthooft,W. A. A. Tjalma. Malignant mixed mtillerian tumor of the ovary and false negative punctures. European Journal of Gynaecological Oncology. 2003. 24(1);70-72.

References

[1] Hellstrom A. C., Tegerstedt G., Silfversward C., P ettersson F.: "Malignant mixed miillerian tumors of the ovary : histopathologic and clinical review of 36 cases". Int. J. Gynecol. Cancer, 1999, 9, 312.

[2] Vergote I., de Wever I., Tjalma W., Van Gramberen M., Decloedt J., Van Dam P.: "Interval debulking surgery: an alternative for primary surgical debulking?". Se min. Surg. Oncol., 2000, 19 (1), 49.

[3] Vergote I., De Wever I., Tjalma W., Van Gramberen M., Decloedt J., Van Dam P.: "Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients". Gynecol. Oneal., 1998, 71 (3), 431.

[4] P rendiville J., Murphy D., Renninson J., Buckley H., Crowther D.: "Carcinosarcoma of the ovary treated over a 10-year period at the Christie Hospital". Int. J. Gynecol. Cancer, 1994, 4, 200.

[5] Morrow C. P., d'Ablaing G., Brady L. W., Blessing A., Hreshchyshyn M. M.: "A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelian and mesenchymal ovarian tumors : A gynecologic oncology group study". Gynecol. Oneal., 1984, 18, 278.

[6] Eicher A., Levenbach C. H. Silva E. G., Burke T. W., Morris M Gershenson D. M.: "Ovarian malignant mixed mullerian tumors treated with platinum-based chemotherapy". Obstet. Gynecol., 1995, 85 (5), 735.

[7] Van Rijswijk R. E. N., Tognon G., Burger C. W., Baak J.P., Kenemans P., Vennorken J.B.: "The effect of chemotherapy on the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract". Int. J. Gynecol. Cancer, 1994, 4, 52.

[8] Eltabbakh G. H., Yadav R.: "Good response of malignant mixed mullerian tumor of the ovary to paclitaxel and cisplatin chemotherapy". Eur. J. Gynaecol. Oncol., 1999, 20 (5-6), 355.

Submission Turnaround Time

Top